{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:52:24Z","timestamp":1791460344951,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.yrtph.2026.106215","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:05:06Z","timestamp":1786464306000},"page":"106215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Toxicological assessment of potential leachables in parenteral drug products: Bioavailability adjustment considerations"],"prefix":"10.1016","volume":"172","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3166-2782","authenticated-orcid":false,"given":"Samuel","family":"Boobier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyn","family":"Chilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Parris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2026.106215_bib1","article-title":"ADMET predictor\u00ae - simulations plus - machine Learning- ADMET property prediction","year":"2026","journal-title":"Simul. Plus"},{"key":"10.1016\/j.yrtph.2026.106215_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0005-2736(70)90221-X","article-title":"Absorption of aliphatic hydrocarbons by rats","volume":"219","author":"Albro","year":"1970","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.yrtph.2026.106215_bib3","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41370-022-00494-x","article-title":"Developing an internal threshold of toxicological concern (iTTC)","volume":"32","author":"Arnot","year":"2022","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"10.1016\/j.yrtph.2026.106215_bib4","series-title":"Applied Pharmacology","first-page":"17","article-title":"Chapter 2 - pharmacokinetics","author":"Bardal","year":"2011"},{"key":"10.1016\/j.yrtph.2026.106215_bib5","doi-asserted-by":"crossref","first-page":"9867","DOI":"10.3390\/ijms23179867","article-title":"Absorption and metabolism of the natural sweeteners erythritol and Xylitol in humans: a dose-ranging study","volume":"23","author":"Bordier","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yrtph.2026.106215_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.yrtph.2016.08.011","article-title":"Assessing safety of extractables from materials and leachables in pharmaceuticals and biologics \u2013 current challenges and approaches","volume":"81","author":"Broschard","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106215_bib7","article-title":"CompTox chemicals dashboard","year":"2025","journal-title":"Dodecamethylcyclohexasiloxane Propert."},{"key":"10.1016\/j.yrtph.2026.106215_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.taap.2010.06.008","article-title":"Pharmacokinetics of bisphenol A in neonatal and adult Sprague-Dawley rats","volume":"247","author":"Doerge","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106215_bib9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.toxlet.2011.09.020","article-title":"Pharmacokinetics of bisphenol A in neonatal and adult CD-1 mice: inter-species comparisons with Sprague-Dawley rats and rhesus monkeys","volume":"207","author":"Doerge","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2026.106215_bib10","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.toxlet.2012.03.008","article-title":"Pharmacokinetics of bisphenol A in serum and adipose tissue following intravenous administration to adult female CD-1 mice","volume":"211","author":"Doerge","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.yrtph.2026.106215_bib11","article-title":"Grouping of substances and read-across","year":"2013","journal-title":"Part 1: Introd. Note"},{"key":"10.1016\/j.yrtph.2026.106215_bib12","series-title":"Guidance on Information Requirements and Chemical Safety Assessment \u2013 Chapter R.7c \u2013 Endpoint Specific Guidance","year":"2024"},{"key":"10.1016\/j.yrtph.2026.106215_bib14","article-title":"Registration dossier - ECHA","volume":"3","year":"2025","journal-title":"Basic Toxicokinetics Didodecyl"},{"key":"10.1016\/j.yrtph.2026.106215_bib15","article-title":"Registration Dossier - ECHA, endpoint summary","year":"2025","journal-title":"Ethylene bis[3,3-bis(3-tert-butyl-4-hydroxyphenyl)butyrate]"},{"key":"10.1016\/j.yrtph.2026.106215_bib16","series-title":"Registration Dossier - ECHA","year":"2025"},{"key":"10.1016\/j.yrtph.2026.106215_bib18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0147-6513(82)90081-1","article-title":"Ecotoxicological profile analysis: VII. Screening chemicals for their environmental behavior by comparative evaluation","volume":"6","author":"Freitag","year":"1982","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.yrtph.2026.106215_bib19","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1021\/jm701122q","article-title":"Generation of a set of simple, interpretable ADMET rules of thumb","volume":"51","author":"Gleeson","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yrtph.2026.106215_bib23","doi-asserted-by":"crossref","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","article-title":"PubChem 2025 update","volume":"53","author":"Kim","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.yrtph.2026.106215_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev. In Vitro Model Select. Develop. Candid."},{"key":"10.1016\/j.yrtph.2026.106215_bib25","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1021\/jm0492002","article-title":"A bioavailability score","volume":"48","author":"Martin","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yrtph.2026.106215_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2023.105494","article-title":"Harmonisation of read-across methodology for drug substance extractables and leachables (E&Ls)","volume":"145","author":"Masuda-Herrera","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106215_bib26","doi-asserted-by":"crossref","first-page":"369","DOI":"10.5731\/pdajpst.2021.012693","article-title":"Development of duration-based non-mutagenic thresholds of toxicological concern (TTCs) relevant to parenteral extractables and leachables (E&Ls)","volume":"76","author":"Masuda-Herrera","year":"2022","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.yrtph.2026.106215_bib28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3109\/10408444.2014.930813","article-title":"Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps","volume":"44","author":"Mattison","year":"2014","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106215_bib29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/10408444.2015.1016216","article-title":"Characterization of the toxicological hazards of hydrocarbon solvents","volume":"45","author":"Mckee","year":"2015","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106215_bib30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejps.2013.08.018","article-title":"Animal versus human oral drug bioavailability: do they correlate?","volume":"57","author":"Musther","year":"2014","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.yrtph.2026.106215_bib31","series-title":"OECD Series on Testing and Assessment, No. 69","article-title":"Chapter 4 - guidance document on the validation of (Quantitative) structure-activity relationship [(Q)SAR] models","year":"2014"},{"key":"10.1016\/j.yrtph.2026.106215_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2020.104802","article-title":"Considerations when deriving compound-specific limits for extractables and leachables from pharmaceutical products: four case studies","volume":"118","author":"Parris","year":"2020","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106215_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2013.06.002","article-title":"Use of category approaches, read-across and (Q)SAR: general considerations","volume":"67","author":"Patlewicz","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106215_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13321-018-0316-5","article-title":"JPlogP: an improved logP predictor trained using predicted data","volume":"10","author":"Plante","year":"2018","journal-title":"J. Cheminf."},{"key":"10.1016\/j.yrtph.2026.106215_bib35","article-title":"RDKit: open-source cheminformatics","year":"2025","journal-title":"Software"},{"key":"10.1016\/j.yrtph.2026.106215_bib36","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/jm901371v","article-title":"Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination","volume":"53","author":"Varma","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yrtph.2026.106215_bib37","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yrtph.2026.106215_bib38","article-title":"Re-evaluation of erythritol (E 968) as a food additive","volume":"21","author":"Younes","year":"2023","journal-title":"EFSA J."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026001881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026001881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:07:00Z","timestamp":1791457620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230026001881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S0273230026001881"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106215","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicological assessment of potential leachables in parenteral drug products: Bioavailability adjustment considerations","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106215"}}